Filing Flows › Comparisons › WHWK vs VERU
Whitehawk Therapeutics vs Veru: WHWK and VERU compared
Whitehawk Therapeutics is the larger company: $7.1M of revenue in its latest quarter (Q1 2025) against $6.7M for Veru (Q4 FY24). Veru is growing faster (+72% against +34% a year earlier). Veru is more profitable, with an operating margin of -112.1% against -213.0%.
Where the money goes: WHWK and VERU
Whitehawk Therapeutics (WHWK) · Q1 2025
Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Veru (VERU) · Q4 FY24
Veru, Q4 FY24: revenue $6.7M (+72% year over year), operating margin -112.1%, net loss $8.5M, operating cash flow −$4.4M. The chart follows the revenue to costs, profit and cash.
| Whitehawk Therapeutics (WHWK) | Veru (VERU) | |
|---|---|---|
| Latest quarter | Q1 2025 | Q4 FY24 |
| Revenue | $7.1M | $6.7M |
| Revenue growth, Y/Y | +34% | +72% |
| Operating margin | -213.0% | -112.1% |
| Net earnings | $73.0M | −$8.5M |
| Net margin | — | -128.2% |
| Operating cash flow | −$11.9M | −$4.4M |
Questions
Which is bigger, Whitehawk Therapeutics or Veru?
Whitehawk Therapeutics is the larger company: $7.1M of revenue in its latest quarter (Q1 2025) against $6.7M for Veru (Q4 FY24).
Is Whitehawk Therapeutics or Veru growing faster?
Veru is growing faster (+72% against +34% a year earlier).
Which is more profitable, Whitehawk Therapeutics or Veru?
Veru is more profitable, with an operating margin of -112.1% against -213.0%.
More: Whitehawk Therapeutics earnings · how Whitehawk Therapeutics makes money · Veru earnings · how Veru makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 8, 2025; 10-K filed Dec 16, 2024). Fiscal quarters can end on different dates. Not investment advice.